Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Vertex Pharmaceuticals, Inc (NASDAQ: VRTX) closed at $450.03 down -10.03% from its previous closing price of $500.19. In other words, the price has decreased by -$10.03 from its previous closing price. On the day, 7.85 million shares were traded.
Ratios:
For a deeper understanding of Vertex Pharmaceuticals, Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.29 and its Current Ratio is at 2.65. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
Canaccord Genuity Upgraded its Sell to Hold on February 12, 2025, whereas the target price for the stock was revised from $408 to $424.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 02 ’25 when Bhatia Sangeeta N. sold 400 shares for $505.86 per share. The transaction valued at 202,344 led to the insider holds 4,831 shares of the business.
Bhatia Sangeeta N. bought 400 shares of VRTX for $202,344 on May 02 ’25. On Mar 13 ’25, another insider, ALTSHULER DAVID, who serves as the EVP, Chief Scientific Officer of the company, sold 3,231 shares for $510.00 each. As a result, the insider received 1,647,810 and left with 23,281 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 10.45 while its Price-to-Book (P/B) ratio in mrq is 7.01.
Stock Price History:
Over the past 52 weeks, VRTX has reached a high of $519.88, while it has fallen to a 52-week low of $377.85. The 50-Day Moving Average of the stock is -8.48%, while the 200-Day Moving Average is calculated to be -4.53%.
Shares Statistics:
A total of 257.00M shares are outstanding, with a floating share count of 256.33M. Insiders hold about 0.29% of the company’s shares, while institutions hold 93.25% stake in the company.
